Nicoletta Bivi

5PUBLICATIONS
25CO-AUTHORS
Pharmaceutical delivery technologiesTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 14, 2021
Safety and Immunogenicity of LY3415244, a Bispecific Antibody Against TIM-3 and PD-L1, in Patients With Advanced Solid Tumors.

Matthew D Hellmann, Nicoletta Bivi, Boris Calderon

|Nov 06, 2020
The method history report: an adaptable tool for communicating immunogenicity assay development and validation.

Kristin Hollister, Huy T Nguyen, Jessie L Bishop

Pageof 1